HUPO 2026 has ended. This guide stays up as the record of who was there. Next: HUPO 2027, Oct 11–15, 2027 in Milan
Pharma and biotech companies at HUPO 2026
Sep 27 – Oct 1, 2026 Singapore ~1.8k attendees Website
12 pharma and biotech companies are at HUPO 2026 — 17 presentations on the program. Most represented: Alkahest (3 on the program), Immatics (3 on the program), Immunocore (2 on the program). 2 of them have their own page in this guide. As of Sep 25, 2026.
Research topic
Top represented
Showing 1–12 of 12 organizations
| Organization | HUPO 2026 Attendance |
|---|---|
Alkahest San Carlos, CA | |
Grifols-owned biotech developing plasma-based therapies for age-related diseases, with large-scale plasma proteomics research. | Talk Tue Sep 29 4:15pm–5:20pm Talk Wed Sep 30 10:30am–12:00pm Workshop Wed Sep 30 12:15pm–1:15pm Poster Wed Sep 30 1:15pm–3:00pm Poster Wed Sep 30 1:15pm–3:00pm |
Immatics Tübingen, Germany | |
Clinical-stage biotech developing T cell receptor-based cancer immunotherapies, using immunopeptidomics to find tumour targets. | Talk Mon Sep 28 10:30am–12:00pm Poster Wed Sep 30 1:15pm–3:00pm Poster Wed Sep 30 1:15pm–3:00pm |
Immunocore Abingdon, United Kingdom | |
Commercial-stage biotech developing T cell receptor bispecific immunotherapies for cancer, infectious and autoimmune diseases. | Poster Wed Sep 30 1:15pm–3:00pm |
Regeneron Tarrytown, NY | |
Biotechnology company that discovers, develops and markets antibody and other medicines. | Poster Tue Sep 29 1:15pm–3:00pm Session Tue Sep 29 4:15pm–5:20pm |
Abvion Biologics Utrecht, Netherlands | |
Utrecht company, founded 2024, discovering therapeutic human antibodies by mass spectrometry-based de novo sequencing of antibodies straight from blood. | Plenary Tue Sep 29 4:15pm–5:20pm |
Bayer Leverkusen, Germany | |
Pharmaceutical and life sciences company headquartered in Leverkusen, Germany. | |
Bertis Gwacheon, South Korea | |
Korean proteomics-based diagnostics company developing blood tests for cancer, including the Mastocheck breast cancer test. | Poster Tue Sep 29 1:15pm–3:00pm |
B Bionsight | |
Korean drug discovery company using chemoproteomics and AI for target identification and off-target profiling. | |
NEOsphere Biotechnologies Martinsried, Germany | |
Drug discovery company using high-throughput proteomics to find molecular glue degraders and their protein targets. | |
Roche Basel, Switzerland | |
Swiss pharmaceutical and diagnostics company headquartered in Basel. | Poster Wed Sep 30 1:15pm–3:00pm |
Talus Bio Seattle, WA | |
Drug discovery company in Seattle developing medicines against transcription factors, using proteomics to measure their activity. | Poster Wed Sep 30 1:15pm–3:00pm |
MSD Rahway, NJ | ○Grant Supporter |
Global pharmaceutical company, known as Merck & Co. in the US and Canada, developing medicines and vaccines. |
Find buyers from pharma and biotech companies
Tell us what you sell and we’ll find the people at these pharma and biotech companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse HUPO 2026 by
Organization type
Research topic
Exhibit hall
Everyone
Not affiliated with or endorsed by the Human Proteome Organization (HUPO) or the HUPO 2026 World Congress. Submit a correction